|
NUP160 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.196200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.091590E-01 |
| Normal-vs-Stage2 |
8.475000E-01 |
| Normal-vs-Stage3 |
3.294300E-02 |
| Normal-vs-Stage4 |
3.930100E-02 |
| Stage1-vs-Stage2 |
3.894200E-01 |
| Stage1-vs-Stage3 |
1.974820E-04 |
| Stage1-vs-Stage4 |
6.583600E-04 |
| Stage2-vs-Stage3 |
8.129900E-02 |
| Stage2-vs-Stage4 |
8.133600E-02 |
| Stage3-vs-Stage4 |
8.892800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.972800E-01 |
| Normal-vs-AfricanAmerican |
8.886200E-02 |
| Normal-vs-Asian |
4.062000E-01 |
| Caucasian-vs-AfricanAmerican |
6.942400E-02 |
| Caucasian-vs-Asian |
5.651200E-01 |
| AfricanAmerican-vs-Asian |
2.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.003200E-01 |
| Normal-vs-Female |
5.878600E-01 |
| Male-vs-Female |
1.858410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.720800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.687800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.330600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.820600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.369400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.058800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.370800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.005380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.274400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.758000E-02 |
| Normal-vs-Grade 2 |
7.786500E-02 |
| Normal-vs-Grade 3 |
3.015000E-01 |
| Normal-vs-Grade 4 |
2.606500E-04 |
| Grade 1-vs-Grade 2 |
1.715600E-01 |
| Grade 1-vs-Grade 3 |
1.075630E-02 |
| Grade 1-vs-Grade 4 |
1.958910E-04 |
| Grade 2-vs-Grade 3 |
2.841400E-03 |
| Grade 2-vs-Grade 4 |
3.51149999966438E-07 |
| Grade 3-vs-Grade 4 |
2.282800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.88919999999771E-05 |
| Normal-vs-ccB subtype |
2.063100E-03 |
| ccA subtype-vs-ccB subtype |
1.01918473660589E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.831400E-01 |
| Normal-vs-N1 |
1.941950E-01 |
| N0-vs-N1 |
1.447020E-01 |
|
|
